Evidence map›Paper›PMID 28233228›Full record

ReviewCurrent urology reports2017

MR/US Fusion Technology: What Makes It Tick?

Srinivas Vourganti, Norman Starkweather, Andrij Wojtowycz

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current urology reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Srinivas VourgantiRush University Medical Center, 1725 W. Harrison Street, Suite 970 POB III, Chicago, IL, 60612, USA. srinivas_vourganti@rush.edu.
Norman StarkweatherState University of New York - Upstate Medical University, 750 E. Adams Street, Syracuse, NY, 13210, USA.
Andrij WojtowyczState University of New York - Upstate Medical University, 750 E. Adams Street, Syracuse, NY, 13210, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MR/US fusion biopsy has emerged as a significant refinement of traditional prostate cancer diagnostic techniques. Utilizing not only quantitative imaging suspicion information from mpMRI but also the spatial accuracy and three-dimensional localization allows such strategies to specifically sample areas of concern with the gland. As such, diagnostic certainty is markedly improved. In this manuscript, we aim to highlight the multidisciplinary approach (amongst urologists, radiologists, pathologists, imaging technologists, nursing staff, and patients) which is required to launch and maintain a successful prostate imaging program.

Indexed as

BiopsyHumansMagnetic Resonance ImagingMaleMultimodal ImagingProstatic NeoplasmsUltrasonographyImagingMRIMR/US fusion biopsyProstate cancer

Identifiers

PMID28233228

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.